Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Arrowhead Pharmaceuticals, Inc.
About ARWR
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. It is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, muscle and central nervous system. It has around 16 clinical-stage investigational medicines (wholly owned and partnered), which range in development stage from Phase I to Phase III. The Company's pipeline products include Plozasiran, Zodasiran, Olpasiran, ARO-RAGE, ARO-MMP7, GSK-4532990, Fazirsiran, GSK5637608, ARO-CFB, ARO-INHBE, ARO-C3, ARO-PNPLA3, ARO-DUX4, ARO-DM1 and ARO-ATXN2.
Find out what a historical investment in Arrowhead Pharmaceuticals, Inc. would be worth today using our ARWR stock calculator.
Market Capitalisation
$10.80B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.75M
High today
$79.00
Low today
$76.26
Open price
$78.16
52-week high
$82.26
52-week low
$14.30
Ready to start your investing journey with Stake?
Open an accountHow do I buy ARWR shares in Australia?
Buying ARWR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Arrowhead Pharmaceuticals, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ARWR
What is the ticker symbol of Arrowhead Pharmaceuticals, Inc.?
The ticker symbol for Arrowhead Pharmaceuticals, Inc. is ARWR.
How much is one share of ARWR?
One share of ARWR is valued at $76.75 as of 16 May 2026.
What is the market capitalisation of Arrowhead Pharmaceuticals, Inc. ARWR?
As of 16 May 2026 Arrowhead Pharmaceuticals, Inc. has a market cap of $10.80B.
What is the 52-week high for Arrowhead Pharmaceuticals, Inc. stock?
The Arrowhead Pharmaceuticals, Inc. 52-week high stock price is $82.26.
What is the 52-week low for Arrowhead Pharmaceuticals, Inc. stock?
The Arrowhead Pharmaceuticals, Inc. 52-week low stock price is $14.30.
Can I buy ARWR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ARWR shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ARWR on Stake
- Buy ARWR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ARWR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ARWR related stocks